Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nick

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Cancer Research|July 29, 2011
Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancerWei Hu, Chunhua Lu, Han Hee Dong, et al.
Gynecologic Oncology|February 26, 2022
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancerChristopher J LaFargue, Katelyn F Handley, Nicole D Fleming, et al.
Cancer Discovery|December 20, 2011
A novel platform for detection of CK+ and CK- CTCsChad V Pecot, Farideh Z Bischoff, Julie Ann Mayer, et al.
Molecular Cancer Therapeutics|August 5, 2010
Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinomaWhitney A Spannuth, Lingegowda S Mangala, Rebecca L Stone, et al.
The New England Journal of Medicine|December 19, 2008
Dicer, Drosha, and outcomes in patients with ovarian cancerWilliam M Merritt, Yvonne G Lin, Liz Y Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Therapeutic Targeting of ATP7B in Ovarian CarcinomaLingegowda S Mangala, Vesna Zuzel, Rosemarie Schmandt, et al.
Journal of Oncology Practice|July 28, 2016
What Is the Real Rate of Surgical Site Infection?Jolyn S Taylor, Claire A Marten, Kimberly A Potts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Targeting aurora kinase with MK-0457 inhibits ovarian cancer growthYvonne G Lin, Anand Immaneni, William M Merritt, et al.
Cancer Research|April 19, 2014
Notch3 pathway alterations in ovarian cancerWei Hu, Tao Liu, Cristina Ivan, et al.
The Journal of Clinical Investigation|April 12, 2016
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawalMonika Haemmerle, Justin Bottsford-Miller, Sunila Pradeep, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Cancer Research|July 29, 2011
Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancerWei Hu, Chunhua Lu, Han Hee Dong, et al.
Gynecologic Oncology|February 26, 2022
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancerChristopher J LaFargue, Katelyn F Handley, Nicole D Fleming, et al.
Cancer Discovery|December 20, 2011
A novel platform for detection of CK+ and CK- CTCsChad V Pecot, Farideh Z Bischoff, Julie Ann Mayer, et al.
Molecular Cancer Therapeutics|August 5, 2010
Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinomaWhitney A Spannuth, Lingegowda S Mangala, Rebecca L Stone, et al.
The New England Journal of Medicine|December 19, 2008
Dicer, Drosha, and outcomes in patients with ovarian cancerWilliam M Merritt, Yvonne G Lin, Liz Y Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Therapeutic Targeting of ATP7B in Ovarian CarcinomaLingegowda S Mangala, Vesna Zuzel, Rosemarie Schmandt, et al.
Journal of Oncology Practice|July 28, 2016
What Is the Real Rate of Surgical Site Infection?Jolyn S Taylor, Claire A Marten, Kimberly A Potts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Targeting aurora kinase with MK-0457 inhibits ovarian cancer growthYvonne G Lin, Anand Immaneni, William M Merritt, et al.
Cancer Research|April 19, 2014
Notch3 pathway alterations in ovarian cancerWei Hu, Tao Liu, Cristina Ivan, et al.
The Journal of Clinical Investigation|April 12, 2016
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawalMonika Haemmerle, Justin Bottsford-Miller, Sunila Pradeep, et al.
Pageof 16